CLSI M33-A

Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE

Clinical and Laboratory Standards Institute, 02/01/2004

Publisher: CLSI

File Format: PDF

$120.00$240.30

Description

Published:01/02/2004

Pages:39

This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.

More CLSI standard pdf

CLSI GP17-A3 (R2018)

Clinical Laboratory Safety; Approved Guideline - Third Edition, GP17A3E

$90.00 $180.00

CLSI MM01-A3

Molecular Methods for Clinical Genetics and Oncology Testing; Approved Guideline-Third Edition, MM01A3E

$90.00 $180.00

CLSI EP17-A2 (R2018)

Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline- Second Edition, EP17A2E

$90.00 $180.00

CLSI M11-A8

Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard - Eighth Edition, M11A8E

$90.00 $180.00